Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Aubrey Capital Management Ltd

Aubrey Capital Management Ltd lowered its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 4.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 14,900 shares of the biotechnology company’s stock after selling 700 shares during the quarter. Axon Enterprise comprises about 2.3% of Aubrey Capital Management Ltd’s portfolio, making the stock its 9th biggest holding. Aubrey Capital Management Ltd’s holdings in Axon Enterprise were worth $5,954,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently bought and sold shares of AXON. Blue Trust Inc. lifted its holdings in shares of Axon Enterprise by 987.5% in the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after acquiring an additional 79 shares during the last quarter. Quent Capital LLC grew its stake in shares of Axon Enterprise by 1,875.0% in the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after buying an additional 75 shares in the last quarter. Asset Dedication LLC purchased a new stake in shares of Axon Enterprise in the 2nd quarter valued at $47,000. Planning Capital Management Corp boosted its holdings in Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after acquiring an additional 55 shares during the period. Finally, Friedenthal Financial acquired a new position in Axon Enterprise in the 3rd quarter valued at about $51,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on AXON. Craig Hallum increased their price target on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Bank of America assumed coverage on shares of Axon Enterprise in a research report on Wednesday, July 17th. They issued a “buy” rating and a $380.00 price target for the company. Northland Securities upped their price objective on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday. Needham & Company LLC lifted their target price on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. Finally, Robert W. Baird boosted their target price on Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $427.83.

Axon Enterprise Price Performance

AXON stock opened at $601.29 on Thursday. The business has a 50 day moving average price of $428.90 and a 200 day moving average price of $353.54. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The stock has a market cap of $45.85 billion, a price-to-earnings ratio of 155.37, a PEG ratio of 14.95 and a beta of 0.94. Axon Enterprise, Inc. has a fifty-two week low of $220.51 and a fifty-two week high of $624.84.

Insiders Place Their Bets

In other news, CEO Patrick W. Smith sold 80,300 shares of the company’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $371.78, for a total value of $29,853,934.00. Following the completion of the transaction, the chief executive officer now owns 3,015,366 shares in the company, valued at approximately $1,121,052,771.48. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. In other Axon Enterprise news, President Joshua Isner sold 25,811 shares of the business’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $359.84, for a total value of $9,287,830.24. Following the completion of the sale, the president now owns 228,166 shares in the company, valued at approximately $82,103,253.44. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Patrick W. Smith sold 80,300 shares of the firm’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the transaction, the chief executive officer now owns 3,015,366 shares in the company, valued at approximately $1,121,052,771.48. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 389,172 shares of company stock valued at $148,393,842. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.